tixagevimab   Click here for help

GtoPdb Ligand ID: 11330

Synonyms: AZD8895 | COV2-2196
Compound class: Antibody
Comment: Tixagevimab is a monoclonal antibody against the surface spike protein of SARS-CoV-2 [1]. It was developed by AstraZeneca. This mAb blocks spike binding to ACE2 and prevents infection in animals.
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
11776 tixagevimab
Synonyms Click here for help
AZD8895 | COV2-2196
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1111
Other databases
GtoPdb PubChem SID 434321765
Search PubMed clinical trials tixagevimab
Search PubMed titles tixagevimab
Search PubMed titles/abstracts tixagevimab